Confluent, Inc. — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Confluent, Inc. (CFLT)
CIK: 0001699838
Period of Report: 2025-02-13

Reporting Person: Narkhede Neha (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-13	Class A Common Stock	C	80000	—	Acquired	100247	Direct
2025-02-13	Class A Common Stock	S	22825	$35.89	Disposed	77422	Direct
2025-02-13	Class A Common Stock	S	57175	$36.35	Disposed	20247	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-13	Stock Option (Right to Buy)	$2.24	M	80000	Disposed	2028-10-21	Class B Common Stock (80000)	Direct
2025-02-13	Class B Common Stock	$	M	80000	Acquired		Class A Common Stock (80000)	Direct
2025-02-13	Class B Common Stock	$	C	80000	Disposed		Class A Common Stock (80000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	1787	Indirect

Footnotes

F1: Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

F2: Shares sold pursuant to a 10b5-1 plan adopted September 13, 2024.

F3: The shares were sold at prices ranging from $35.11 to $36.10 The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The shares were sold at prices ranging from $36.11 to $36.89. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Includes 963 shares received in a pro rata partnership distribution.

F6: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments with a vesting commencement date of June 23, 2021, subject to Reporting Person's continuous service through each such vesting date.